When Chinese patients with plasma cell disorders encountered the nationwide Omicron outbreak (December 2022): a real-world multicenter and multiregional study

The latest Omicron outbreak results in higher rates of severe infection and mortality in PCD patients compared with the general population in China, highlighting the need to protect this vulnerable population during the pandemic. Recent use of anti-CD38 mAb and CAR-T therapy are associated with poorer clinical courses and outcomes of PCD patients with COVID-19.

Authors

Institutions

Publication Details

Journal
Hematology
Published
2024-10-07
DOI
https://doi.org/10.1080/16078454.2024.2411741
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

When Chinese patients with plasma cell disorders encountered the nationwide Omicron outbreak (December 2022): a real-world multicenter and multiregional study

Donghua He, Xincheng Jiang, Zhenshu Xu, Fengyan Jin et al.
Hematology
SARS-CoV-2 and COVID-19 Research
article

When Chinese patients with plasma cell disorders encountered the nationwide Omicron outbreak (December 2022): a real-world multicenter and multiregional study

Donghua He, Xincheng Jiang, Zhenshu Xu, Fengyan Jin, Gang An, Xiaoyan Han, Jian Hou, Jingsong He, Shuchan Li, Songfu Jiang, Qingxiao Chen, Yi Zhao, Yang Yang, Qingming Wang, Yi Li, Zhen Cai, Wenjun Wu, Gaofeng Zheng
article en

Abstract

The latest Omicron outbreak results in higher rates of severe infection and mortality in PCD patients compared with the general population in China, highlighting the need to protect this vulnerable population during the pandemic. Recent use of anti-CD38 mAb and CAR-T therapy are associated with poorer clinical courses and outcomes of PCD patients with COVID-19.

HematologyVol. 29(1)
Fujian Medical University (CN), Nanchang University (CN), Jilin University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Wenzhou Medical University (CN), Renji Hospital (CN), First Affiliated Hospital of Wenzhou Medical University (CN), Second Affiliated Hospital of Nanchang University (CN), First Hospital of Jilin University (CN), Institute of Hematology & Blood Diseases Hospital (CN), Zhejiang University (CN)
National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province
Openalex Percentile: Top 78%
SARS-CoV-2 and COVID-19 Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.